Get the Stockscreener App
5.28
4.55%
0.23
Aethlon Medical Inc stock is traded at $5.28, with a volume of 58,153.
It is up +4.55% in the last 24 hours and up +259.18% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$5.05
Open:
$5
24h Volume:
58,153
Relative Volume:
1.00
Market Cap:
$3.75M
Revenue:
$574.20K
Net Income/Loss:
$-7.15M
P/E Ratio:
-0.3325
EPS:
-15.8778
Net Cash Flow:
$-7.00M
1W Performance:
-12.15%
1M Performance:
+259.18%
6M Performance:
-54.48%
1Y Performance:
-84.90%
1-Day Range:
$5.00
$5.455
1-Week Range:
$4.975
$6.18
52-Week Range:
$1.41
$35.97
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
5.28 | 3.75M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
104.69 | 181.15B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.47 | 122.12B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
293.32 | 112.51B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.16 | 63.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.10 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Certain Common Stock of Aethlon Medical, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2026. - www.marketscreener.com
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical Corrects 8-K: Preferred Stock Proposal Rejected by Shareholders - Minichart
Form 8K Aethlon Medical Inc For: 1 October By Investing.com - Investing.com Nigeria
Aethlon Medical shareholders approve equity plan amendments and board elections - Investing.com
AEMD: All proposals except preferred stock authorization were approved, with no stockholder questions - TradingView
Aethlon Medical (NasdaqCM:AEMD) Stock Forecast & Analyst Predictions - Simply Wall Street
North Immunology, Aethlon Merge to Advance NOR-101 for AD - Dermatology Times
What Does Aethlon Medical (NASDAQ:AEMD) Reveal About Penny Stocks? - Kalkine Media
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) - PR Newswire
Aethlon Stock Pulls Back: What's Going On? - Benzinga
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral - Investing.com
Aethlon Medical Q1 2027 Earnings Call Transcript - Benzinga
Aethlon Stock Pulls Back: What's Going On? - TradingView
Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology - Procopio
Aethlon Medical To Merge With North Immunology And Raise $180 Million To Advance Atopic Dermatitis Drug NOR-101 - Pulse 2.0
North Immunology to go public via Aethlon reverse merger backed by USD 180m PIPE - AllSci
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology - Pharmaceutical Executive
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Yahoo Finance
North Immunology deal makes Aethlon (NASDAQ: AEMD) a minority owner - Stock Titan
$180 million fuels Aethlon Medical (NASDAQ: AEMD) merger built around a new skin-disease antibody - Stock Titan
Aethlon Medical stock soars over 400% on North Immunology merger deal - Investing.com
Aethlon Medical (AEMD) Announces Merger with North Immunology, M - GuruFocus
Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing - TradingView
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis - Yahoo Finance
Why Did Aethlon Medical Stock Jump 4X on Thursday?Aethlon Medical (NASDAQ:AEMD) - benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Aethlon Medical Stock Short Interest Rises to 65.04% - Quiver Quantitative
Aethlon Medical | DEFA14A: Others - Moomoo
Aethlon Medical (NASDAQ: AEMD) Schedules October 1 Vote on Major Stock Issuance and Equity Plan Expansion - kalkinemedia.com
Aethlon Medical (NASDAQ: AEMD) Confirms 1.6 Million Shares Outstanding After Full Exercise of Pre-Funded Warrants - kalkinemedia.com
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusSocial Sentiment - vinanet.vn
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusStop Loss Guidance - siam.in
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aethlon Medical surges as recent clinical progress meets a very small post-split float - Quiver Quantitative
AEMD Stock Slides As Traders Eye Hemopurifier And Q1 Call - StocksToTrade
AEMD Stock Pulls Back As Traders Eye Q1 Earnings And Hemopurifier Focus - timothysykes.com
Aethlon Medical Inc. (AEMD) Key Financial Ratios – Valuation, Profitability & More - Value Research
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 - Eastern Progress
Trending Stocks Today | Aethlon Medical Shoots up 41.93% Post-Market - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market SessionAethlon Medical (NASDAQ:AEMD), Modular - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Medical Tech Stock Aethlon Medical (Nasdaq: AEMD) Treats Second Patient in Australian Hemopurifier Cancer Trial - investorideas.com
Aethlon Medical (AEMD) sets vote on 200M new shares, 20M preferred - Stock Titan
Aethlon (AEMD) Quarterly Results: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Ends Down 3.81%Earnings Risk Report - vinanet.vn
Aethlon Medical at emerging growth conference: early cancer signal builds By Investing.com - Investing.com South Africa
Aethlon Medical at emerging growth conference: early cancer signal builds By Investing.com - Investing.com Nigeria
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
12.14%
5.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):